Funding Clinical-Stage Drug Development Companies

Maximum Amount: On Request

Funding Source Details

Listed on Oct 4, 2024(Renewed on Nov 18, 2025)

Thank you for being in touch!
As backstop investors we are focused on capital markets and offering a true alternative that really works to the traditional VC investment, allowing companies to have a Plan B in case VC funding becomes challenging or VC valuations do not meet expectations.
We are investing via equity subscription, subject to public listing, share price, and liquidity of the stock. Additionally, we are covering 100% of the public listing expenses for the primary European direct listing which makes us a leading in-kind IPO investor. We consider this as a Plan B in case in the VC fundraising or valuation is challenging.
We do not sell any consultancy services and acting as investors, we do not have retainer, hidden fees, downpayments, legal fees for due diligence etc.
If you are looking for VC alternative and open to go public, please feel free to contact.

change currency

Financials (USD)

Maximum Amount Not Disclosed

Converted From EUR

Exchange Rate $1.17

Disclaimer: DealStream has not independently verified any of the information in this listing and makes no warranty as to its accuracy or completeness. This listing does not constitute an offer to sell, solicit or make an offer to buy an investment interest. Offers to sell, or the solicitation of offers to buy, any security can only be made through official offering documents, such as a subscription agreement and private placement memorandum. Read DealStream's Terms Of Use before responding to any listing. Learn how to stay safe in our marketplace.

Request Information

Want to learn more about this listing? Log in now. New to DealStream? Discover how artificial intelligence can help you find better deals! Sign up for a Free Account today and get your first Search Genius deal tomorrow.